Do the identified COL1A1 or COL1A2 variants confirm arthrochalasia-type Ehlers-Danlos syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Do COL1A1 or COL1A2 Variants Confirm Arthrochalasia EDS?

Yes, specific pathogenic variants in COL1A1 or COL1A2 genes can confirm arthrochalasia-type Ehlers-Danlos syndrome (aEDS), but only when they affect exon 6 or its splice sites, leading to loss of the N-terminal propeptide cleavage site of type I procollagen. The clinical phenotype must also align with aEDS features to establish the diagnosis.

Genetic Confirmation Criteria

The molecular diagnosis of aEDS is highly specific:

  • Classic aEDS (autosomal dominant): Heterozygous variants causing complete or partial skipping of exon 6 in COL1A1 or COL1A2 1, 2
  • Rare recessive form: Homozygous missense variant c.2050G>A (p.Glu684Lys) in COL1A1, predominantly reported in Saudi Arabian families as a founder mutation 3, 4

Critical distinction: Not all COL1A1/COL1A2 variants cause aEDS. These genes are also responsible for:

  • Osteogenesis imperfecta (OI) - most common
  • Classical EDS (cEDS) - arginine-to-cysteine substitutions 5, 6
  • Vascular EDS features - certain glycine substitutions 6
  • COL1-related overlap disorders 7, 6

Clinical Features Required for Diagnosis

The genetic finding must correlate with the characteristic aEDS phenotype 1, 2:

Major features (must be present):

  • Congenital bilateral hip dislocation
  • Severe generalized joint hypermobility
  • Recurrent joint subluxations/dislocations
  • Skin hyperextensibility
  • Muscle hypotonia (especially in infancy)

Additional features:

  • Mild dysmorphic facial features
  • Kyphoscoliosis
  • Fractures (more common with COL1A1 exon 6 variants) 2
  • Potential wheelchair dependence in adulthood (4/12 patients in one series) 2

Genotype-Phenotype Correlations

Important clinical distinctions 2, 6:

  • COL1A1 exon 6 variants: More severe musculoskeletal involvement, higher fracture risk, more likely to require orthopedic interventions
  • COL1A2 exon 6 variants: Similar joint hypermobility but potentially less severe bone fragility
  • Homozygous p.Glu684Lys: Intermediate severity between severe neonatal OI and classical EDS, with prominent hypotonia and arthrochalasia features 3

Diagnostic Algorithm

When COL1A1/COL1A2 variants are identified:

  1. Determine variant location and type:

    • Exon 6 or splice site affecting exon 6 → likely aEDS
    • Glycine substitutions near N-proteinase cleavage site → possible aEDS or overlap disorder 7
    • Arginine-to-cysteine substitutions → likely cEDS, not aEDS 5, 6
    • Other frameshift/nonsense variants → likely OI, not aEDS
  2. Assess clinical phenotype dominance:

    • Predominant joint hypermobility + congenital hip dislocation → aEDS
    • Predominant fractures + bone fragility → OI
    • Mixed features → COL1-related overlap disorder 7, 6
  3. Evaluate for vascular complications:

    • Screen for arterial fragility even in aEDS phenotypes (reported in 4/15 overlap cases) 6
    • Echocardiography recommended (abnormalities found in 2/10 patients) 2

Critical Pitfalls to Avoid

Do not assume all COL1A1/COL1A2 variants cause aEDS 8. The 2001 European Heart Journal guideline notes that mutations in these genes are "not specific" and are found across multiple EDS types and OI. The specific molecular mechanism (exon 6 skipping) is what defines aEDS.

Beware of misclassification: One case initially diagnosed as hypermobile EDS (hEDS) was later found to have a COL1A2 variant 6. This highlights that some clinically diagnosed hEDS cases may have molecular diagnoses in COL1A2.

Consider recessive inheritance: In consanguineous families or when both parents are carriers, look for the homozygous p.Glu684Lys variant, which presents with severe congenital hypotonia that may initially mimic neuromuscular disorders 3.

Management Implications

Once aEDS is genetically confirmed 2:

  • Orthopedic surveillance: Hip surgery required in 5/12 patients, spinal surgery in 3/12
  • Fracture management: Bisphosphonates may be needed (1/12 patients required treatment)
  • Cardiovascular monitoring: Echocardiography despite lower vascular risk than vascular EDS
  • Pregnancy counseling: Preterm labor risk but generally manageable (one patient had two successful pregnancies)
  • Functional prognosis: Majority of adults can maintain careers, but mobility aids may be necessary

The variant alone does not confirm aEDS—correlation with the clinical phenotype, particularly congenital hip dislocation and severe joint hypermobility, is essential for accurate diagnosis 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.